Research and Clinical Trials

Title  
Clinical Trial of CoenzymeQ10 and Lisinopril in Muscular Dystrophies
Brief Description  
The study will help determine if CoQ10 or lisinopril improve the decline in cardiac muscle function that occurs in muscular dystrophies. Study Details: The study is a multicenter study being conducted through the Cooperative International Neuromuscular Research Group (CINRG) and will include 120 participants aged 8 and up with Duchenne, Becker, or autosomal recessive limb-girdle (specifically: LGMD 2C-2F and 2I) muscular dystrophies that have no clinical cardiac symptoms. Participants will
Who may be Eligible  
120 participants aged 8 and up with Duchenne, Becker, or autosomal recessive limb-girdle (specifically: LGMD 2C-2F and 2I) muscular dystrophies that have no clinical cardiac symptoms.
Specialty/Disorder  
DMD - Muscular Dystrophies
IRB Number  
05-10-09B
Principal Investigator  
Sparks, Susan

For More Information, Contact   Jaime  L.  Shue , RN
Phone:  (704) 446-6253  Fax:  (704) 446-1915 
Email:  jamie.shue@carolinashealthcare.org
Address:  1010 Edgehill Road North Charlotte, NC 28207
Close